Shares of Zoetis were rising Tuesday.
Dreamstime
Zoetis
shares were rising Tuesday after the animal health provider posted fourth-quarter revenue that slightly beat expectations and offered upbeat full-year guidance.
Zoetis
(ticker: ZTS) posted fourth-quarter revenue of just more than $2 billion and adjusted earnings of $1.15 a share, slightly beating on revenue and mirroring earnings expectations, according to FactSet. Fourth-quarter revenue within the company’s U.S. segment rose year over year, while the international segment was “essentially flat on a reported basis,” according to the company.
The company also issued a full-year revenue guidance range of $8.575 billion to $8.725 billion, higher than revenue of $8.1 billion recorded for 2022.
“In 2022, Zoetis delivered another strong year of performance thanks to our diverse portfolio, global scale and talented colleagues,” said Kristin Peck, chief executive officer, in the company’s earnings press release. “We grew revenue 8% operationally, driven by our innovative companion animal franchises across parasiticides, dermatology and pain.”
Shares of Zoetis climbed 5.5% to $172.05. It was one of the best performers in the
S&P 500
Tuesday, according to Dow Jones Market Data.
Write to Emily Dattilo at emily.dattilo@dowjones.com
Credit: marketwatch.com